Nektar Therapeutics (NKTR) Earnings Date & Reports

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NKTR is expected to report earnings to fall 94.51% to -10 cents per share on August 06

Nektar Therapeutics NKTR Stock Earnings Reports

Q2'26

Est.

$-0.10

Q1'26

Missed

by $1.63

Q4'25

Missed

by $1.59

Q3'25

Missed

by $1.68

Q2'25

Missed

by $2.58

The last earnings report on May 07 showed earnings per share of -182 cents, missing the estimate of -18 cents. With 1.17M shares outstanding, the current market capitalization sits at 1.90B.

View a ticker or compare two or three

Compare

NKTR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NKTR